One such example involved a patient who was referred to clinic for uncontrolled depression while taking a CYP2C19-guided SSRI; upon medication reconciliation, the pharmacist learned that the patient was taking a CYP2D6-guided opioid as well. The gene discussed is CYP2D6; the disease is depressive symptom measurement.